Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 18.23M | P/E | - | EPS this Y | 7.10% | Ern Qtrly Grth | - |
Income | -53.05M | Forward P/E | -0.58 | EPS next Y | 60.10% | 50D Avg Chg | 2.00% |
Sales | 8.24M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -27.00% |
Dividend | N/A | Price/Book | 0.29 | EPS next 5Y | - | 52W High Chg | -80.00% |
Recommedations | 3.00 | Quick Ratio | 0.28 | Shares Outstanding | 36.03M | 52W Low Chg | 40.00% |
Insider Own | 7.33% | ROA | -36.10% | Shares Float | 24.16M | Beta | 0.18 |
Inst Own | 8.61% | ROE | -93.63% | Shares Shorted/Prior | 306.62K/201.22K | Price | 0.70 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 143,429 | Target Price | - |
Oper. Margin | -1,529.44% | Earnings Date | Mar 29 | Volume | 39,423 | Change | -2.10% |
About NightHawk Biosciences, Inc.
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.